drugset / Trial / NCT06236308
TTAX03 for the Treatment of Lumbosacral Facet Joint Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a pilot study examining the safety and efficacy of a single intra-articular (IA) injection of TTAX03 per joint to relieve severe spinal facet joint (FJ) pain and improve function in subjects with facet joint pain (FJP) in the lumbosacral region. The design is randomized, double blinded, placebo controlled and dose-group sequential.
Timeline
- Start
- 2024-07-15
- Primary completion
- 2025-01-31
- Completion
- 2025-03-04
Outcome
Outcome not reported
Stopped: “Study was stopped due to reprioritization for active studies”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TTAX03 | Other / unclassified | 10 mg | Other |
| Subject | TTAX03 | Other / unclassified | 25 mg | Other |
Indications
No indication recorded.